Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Conditions

• HIV
• Hepatitis C
• Liver Fibrosis

Interventions

• DRUG: Raltegravir
• DRUG: Ritonavir-boosted protease inhibitor

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborators

• [object Object]
• [object Object]